Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Issa

Chayapathy Issa, Madanpalle IN

Patent application numberDescriptionPublished
20100144800 EXTENDED RELEASE TABLET FORMULATION OF NIACIN - The present invention relates to an extended release tablet formulation comprising niacin and a release retarding agent selected from hydroxypropyl cellulose, polyethylene oxide or mixtures thereof.06-10-2010

Chayapathy Issa, Andhra Pradesh IN

Patent application numberDescriptionPublished
20090162449STABLE ORAL BENZIMIDAZOLE COMPOSITIONS AND PROCESS OF PREPARATION THEREOF - The present invention relates to stable oral compositions of one or more benzimidazole compounds and processes for their preparation. Also provided are methods for treating various gastrointestinal disorders.06-25-2009

Chayapathy Issa, Madanapalle IN

Patent application numberDescriptionPublished
20100178341BILAYERED TABLET COMPRISING NIACIN AND HMG-CoA REDUCTASE INHIBITOR - The present invention relates to a bilayered tablet comprising: a slow release layer comprising niacin and release retarding agent; and an immediate release layer comprising HMG-CoA reductase inhibitor.07-15-2010

Omneya Issa, Ottawa CA

Patent application numberDescriptionPublished
20110310978MULTILAYER DECODING USING PERSISTENT BITS - The invention relates to a method of iterative multi-layer decoding of a multimedia communication signal, wherein persistent bits from various upper layers of the employed protocol stack are used in error correction decoding at a lower error-correction layer. The method includes saving persistent bits from successfully decoded FEC frames in memory, and using a subset of the saved bits in decoding of future frames. A smart controller is used to analyze frames for the presence and location of persistent bits, for saving thereof in memory, and for inserting saved persistent bits into a next frame at successive decoding iterations thereof.12-22-2011

Romeo Issa, Ottawa CA

Patent application numberDescriptionPublished
20100332537System And Method For Optimizing The De-Identification Of Data Sets - A method, system and computer memory for optimally de-identifying a dataset is provided. The dataset from a storage device. The equivalence classes within the dataset is determined. A lattice is determined defining anonymization strategies. A solution set for the lattice is generated. Optimal node from the solution set is determined. The dataset is then de-identified using the generalization defined by the optimal node and can then be stored on the storage device.12-30-2010

William Issa, Nunawading AU

Patent application numberDescriptionPublished
20100009973Integrase Inhibitors 3 - The present invention provides a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Compounds of formula (I) are also provided.01-14-2010
20100168063BICYCLIC PYRIMIDINONES AND USES THEREOF - The present invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. Further provided is a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. A pharmaceutical composition or medicament comprising a compound of Formula I is also provided.07-01-2010
20110009366BICYCLIC PYRIMIDINONES AND USES THEREOF - The present invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. Further provided is a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. A pharmaceutical composition or medicament comprising a compound of Formula I is also provided.01-13-2011

Yasmin Issa, Mainz DE

Patent application numberDescriptionPublished
20110171290INHIBITION OF ANGIOGENESIS AND TUMOR METASTASIS - The present invention relates to an anti L1-CAM antibody for use in a method for the treatment of a disease in a patient which can be treated by inhibition of angiogenesis, wherein the administration of said anti L1-CAM antibody results in the inhibition of angiogenesis and/or tumor metastasis.07-14-2011

Zainab Ibrahim Issa, Upper Hutt NZ

Patent application numberDescriptionPublished
20090163433ANTHELMINTIC AND/OR INSECTICIDE DEVELOPMENT - The use of a nucleic acid molecule encoding FAS in a nematode or arthropod, or a fragment or variant thereof, to identify or produce FAS as a target for: endectocide; anthelmintic and/or insecticide; development.06-25-2009